Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.17
-0.02 (-0.15%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Cross Country Healthcare Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 105.58 | 108.74 | 81.63 | 17.09 | 3.6 | 1.04 |
Cash & Short-Term Investments | 105.58 | 108.74 | 81.63 | 17.09 | 3.6 | 1.04 |
Cash Growth | 30.84% | 33.20% | 377.55% | 374.31% | 247.88% | -35.25% |
Accounts Receivable | 176.64 | 167.51 | 223.24 | 372.35 | 641.61 | 493.91 |
Other Receivables | 7.41 | 8.45 | 19.64 | 17.72 | 18.35 | 5.04 |
Total Trade Receivables | 184.05 | 175.96 | 242.88 | 390.07 | 659.96 | 498.95 |
Other Current Assets | 8.67 | 8.89 | 10.49 | 9.71 | 12.11 | 8.29 |
Total Current Assets | 298.3 | 293.59 | 335 | 416.88 | 675.67 | 508.27 |
Net Property, Plant & Equipment | 29.09 | 29.98 | 31.32 | 29.94 | 22.92 | 23.32 |
Other Intangible Assets | 25.76 | 27.64 | 42.19 | 54.47 | 44.72 | 48.24 |
Goodwill | 63.8 | 63.8 | 135.06 | 135.43 | 163.27 | 119.49 |
Other Long-Term Assets | 34.11 | 33.94 | 45.69 | 44.35 | 41.26 | 33.48 |
Total Assets | 451.07 | 448.95 | 589.25 | 681.06 | 947.84 | 732.81 |
Accounts Payable | 47.6 | 46.03 | 64.95 | 92.82 | 185.51 | 109.75 |
Accrued Expenses | 39.52 | 28.38 | 47.65 | 52.3 | 72.61 | 65.58 |
Current Portion of Long-Term Debt | - | - | - | - | - | 4.18 |
Current Portion of Leases | 0.97 | 1.16 | 2.09 | 2.6 | 4.13 | 4.09 |
Other Current Liabilities | 2.47 | 2.18 | 5.72 | 8.35 | 9.4 | 16.17 |
Total Current Liabilities | 90.57 | 77.76 | 120.4 | 156.08 | 271.64 | 199.77 |
Long-Term Debt | - | - | - | - | 148.74 | 176.37 |
Long-Term Leases | 1.07 | 1.16 | 1.78 | 2.66 | 4.88 | 10.85 |
Other Long-Term Liabilities | 46.63 | 47.22 | 48.11 | 54.67 | 65.37 | 48.29 |
Total Long-Term Liabilities | 47.7 | 48.37 | 49.89 | 57.34 | 218.98 | 235.51 |
Total Liabilities | 138.27 | 126.13 | 170.29 | 213.41 | 490.62 | 435.28 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 195.55 | 201.17 | 202.34 | 236.42 | 292.88 | 321.55 |
Accumulated Other Comprehensive Income | -1.69 | -1.56 | -1.44 | -1.39 | -1.39 | -1.29 |
Retained Earnings | 118.94 | 123.21 | 218.06 | 232.62 | 165.73 | -22.74 |
Total Common Shareholders' Equity | 312.81 | 322.82 | 418.96 | 467.65 | 457.22 | 297.53 |
Shareholders' Equity | 312.81 | 322.82 | 418.96 | 467.65 | 457.22 | 297.53 |
Total Liabilities & Equity | 451.07 | 448.95 | 589.25 | 681.06 | 947.84 | 732.81 |
Total Debt | 2.04 | 2.32 | 3.87 | 5.27 | 157.75 | 195.49 |
Net Cash (Debt) | 103.54 | 106.42 | 77.76 | 11.83 | -154.14 | -194.45 |
Net Cash Growth | -2.71% | 36.85% | 557.50% | - | - | - |
Net Cash Per Share | 3.21 | 3.28 | 2.33 | 0.33 | -4.11 | -5.20 |
Book Value | 312.81 | 322.82 | 418.96 | 467.65 | 457.22 | 297.53 |
Book Value Per Share | 9.71 | 9.96 | 12.55 | 13.18 | 12.18 | 7.96 |
Tangible Book Value | 223.24 | 231.38 | 241.71 | 277.75 | 249.23 | 129.79 |
Tangible Book Value Per Share | 6.93 | 7.14 | 7.24 | 7.83 | 6.64 | 3.47 |